Source: Essentially Sports
Aryna Sabalenka has voiced her support for the Women's Tennis Association's (WTA) new initiative requiring mandatory gene testing for all players on tour. The policy, which took effect on July 21, aims to screen for the SRY gene through a one-time test involving a cheek swab, blood sample, or saliva test. This move aligns with broader eligibility policies introduced by the International Olympic Committee earlier this year. Sabalenka highlighted the significance of this initiative, stating, "It’s really important" for ensuring fair competition and player safety within the sport. The implementation of these tests marks a significant step in the ongoing discussion about inclusivity and fairness in women's tennis.
